The Medicine Maker’s annual cell and gene supplement returns with a league of extraordinary professionals sharing their insight on how they expect the industry to develop, whilst exercising an optimistic caution for the future of this still young area of expertise. Topics discussed include CRISPR, AI, regulated supply chains, and the important role of accurate information regarding new therapies. Illustrious names joining the discussion include Eric Rhodes, ERS Genomics; Monika Paul, Caszyme; Sumukhi Sreevatsan, IMAPAC; Vered Caplan, Orgenesis; and Chelsea Pratt, Bio-Rad Laboratories. Also in the supplement:
- Investor enthusiasm versus the economic crisis
- Juggling industry with academia
- Sitting Down With Tirtha Chakraborty
Get ready for the future. Download the supplement here
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
